PT2642980T - Formulação pediátrica - Google Patents
Formulação pediátricaInfo
- Publication number
- PT2642980T PT2642980T PT117943076T PT11794307T PT2642980T PT 2642980 T PT2642980 T PT 2642980T PT 117943076 T PT117943076 T PT 117943076T PT 11794307 T PT11794307 T PT 11794307T PT 2642980 T PT2642980 T PT 2642980T
- Authority
- PT
- Portugal
- Prior art keywords
- pediatric formulation
- pediatric
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41666210P | 2010-11-23 | 2010-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2642980T true PT2642980T (pt) | 2020-06-24 |
Family
ID=45316075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT117943076T PT2642980T (pt) | 2010-11-23 | 2011-11-23 | Formulação pediátrica |
Country Status (14)
Country | Link |
---|---|
US (3) | US20140147497A1 (pt) |
EP (1) | EP2642980B8 (pt) |
CA (1) | CA2818565A1 (pt) |
CY (1) | CY1123700T1 (pt) |
DK (1) | DK2642980T3 (pt) |
ES (1) | ES2793724T3 (pt) |
HR (1) | HRP20200691T1 (pt) |
HU (1) | HUE049344T2 (pt) |
LT (1) | LT2642980T (pt) |
PL (1) | PL2642980T3 (pt) |
PT (1) | PT2642980T (pt) |
RS (1) | RS60203B1 (pt) |
SI (1) | SI2642980T1 (pt) |
WO (1) | WO2012071535A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2730279T3 (pl) * | 2012-11-09 | 2015-12-31 | K H S Pharma Holding Gmbh | Preparaty cynakalcetu o natychmiastowym uwalnianiu |
US10016374B2 (en) | 2013-06-26 | 2018-07-10 | Jubilant Generics Limited | Disintegrant free composition of Cinacalcet |
EP3116487A1 (en) * | 2014-03-14 | 2017-01-18 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmaceutical composition of cinacalcet |
KR101680464B1 (ko) | 2015-04-17 | 2016-11-28 | 가톨릭대학교 산학협력단 | 시나칼셋을 유효성분으로 함유하는 당뇨병성 미세혈관 합병증의 예방 및 치료용 약학적 조성물 |
EP3241549A1 (en) | 2016-05-02 | 2017-11-08 | Sun Pharmaceutical Industries Limited | Sprinkle composition of cinacalcet |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965252A (en) * | 1988-06-28 | 1990-10-23 | Hauser-Kuhrts, Inc. | Cholesterol-lowering combination compositions of guar gum and niacin |
HUE044279T2 (hu) * | 2003-09-12 | 2019-10-28 | Amgen Inc | Cinakalcet HCl gyors feloldódású készítménye |
MX2009002335A (es) * | 2006-09-01 | 2009-03-20 | Teva Pharma | Composiciones solidas de un compuesto activo receptor de calcio. |
WO2008064202A2 (en) * | 2006-11-20 | 2008-05-29 | Dr. Reddy's Labortories, Ltd. | Modified-release formulations of calcium receptor-active compounds |
-
2011
- 2011-11-23 WO PCT/US2011/062085 patent/WO2012071535A2/en active Application Filing
- 2011-11-23 ES ES11794307T patent/ES2793724T3/es active Active
- 2011-11-23 RS RS20200484A patent/RS60203B1/sr unknown
- 2011-11-23 EP EP11794307.6A patent/EP2642980B8/en active Active
- 2011-11-23 US US13/885,838 patent/US20140147497A1/en not_active Abandoned
- 2011-11-23 SI SI201131874T patent/SI2642980T1/sl unknown
- 2011-11-23 LT LTEP11794307.6T patent/LT2642980T/lt unknown
- 2011-11-23 DK DK11794307.6T patent/DK2642980T3/da active
- 2011-11-23 HU HUE11794307A patent/HUE049344T2/hu unknown
- 2011-11-23 CA CA2818565A patent/CA2818565A1/en not_active Abandoned
- 2011-11-23 PT PT117943076T patent/PT2642980T/pt unknown
- 2011-11-23 PL PL11794307T patent/PL2642980T3/pl unknown
-
2017
- 2017-05-24 US US15/603,996 patent/US20180098940A1/en not_active Abandoned
-
2018
- 2018-09-07 US US16/124,845 patent/US20190216737A1/en not_active Abandoned
-
2020
- 2020-04-29 HR HRP20200691TT patent/HRP20200691T1/hr unknown
- 2020-06-17 CY CY20201100554T patent/CY1123700T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2642980B8 (en) | 2020-06-03 |
SI2642980T1 (sl) | 2020-07-31 |
RS60203B1 (sr) | 2020-06-30 |
EP2642980B1 (en) | 2020-04-08 |
WO2012071535A3 (en) | 2012-08-16 |
EP2642980A2 (en) | 2013-10-02 |
US20140147497A1 (en) | 2014-05-29 |
WO2012071535A2 (en) | 2012-05-31 |
HRP20200691T1 (hr) | 2020-07-24 |
CY1123700T1 (el) | 2022-03-24 |
ES2793724T3 (es) | 2020-11-16 |
CA2818565A1 (en) | 2012-05-31 |
PL2642980T3 (pl) | 2020-09-21 |
US20180098940A1 (en) | 2018-04-12 |
HUE049344T2 (hu) | 2020-09-28 |
LT2642980T (lt) | 2020-05-25 |
DK2642980T3 (da) | 2020-06-22 |
US20190216737A1 (en) | 2019-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2491491B (en) | Anaesthetic formulation | |
GB2481881B (en) | Liquid formulations | |
PL2865271T3 (pl) | Ulepszony preparat | |
EP2531023A4 (en) | ENHANCED FORMULATION | |
GB2486567B (en) | Pharmaceutical formulation | |
ZA201206589B (en) | Incotine containing formulation | |
RS60203B1 (sr) | Pedijatrijska formulacija | |
PL2359816T3 (pl) | Formulacje aripiprazolu | |
AP2013006687A0 (en) | Formulations | |
GB201013513D0 (en) | Formulations | |
GB201010667D0 (en) | Formulations | |
GB201006326D0 (en) | Formulation | |
AP2013006689A0 (en) | Formulations | |
GB201005992D0 (en) | Formulation | |
GB201002000D0 (en) | Formulation | |
GB201001978D0 (en) | Formulation | |
PL393180A1 (pl) | Preparat weterynaryjny | |
PL390421A1 (pl) | Preparat weterynaryjny | |
GB201013871D0 (en) | Liquid formulations | |
GB201008873D0 (en) | Liquid formulations | |
GB201018648D0 (en) | Formulations | |
GB201018647D0 (en) | Formulations | |
GB201018645D0 (en) | Formulations | |
GB201012589D0 (en) | Formulations | |
GB201010494D0 (en) | Formulations |